Tumour angiogenesis: vascular growth and survival

被引:63
作者
Giatromanolaki, A
Sivridis, E
Koukourakis, MI
机构
[1] Democritus Univ Thrace, Dept Pathol, Alexandroupolis 68100, Greece
[2] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis 68100, Greece
关键词
angiogenesis; tumour angiogenic ability (TAA); vascular survival ability (VSA);
D O I
10.1111/j.1600-0463.2004.apm11207-0804.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Angiogenesis starts at the edge of a malignant epithelial tumour concurrently with tumour cell invasion and stromatogenesis, i.e. the formation of specific connective tissue stroma amenable to easy penetration by endothelial and tumour cells. However, as the tumour continues its growth, the edge becomes the inner tumour area, and a new invading tumour front is formed by the multiplying malignant cells which outflank the initial edge. This process, which repeats itself again and again, forms the "relay race" model of tumour vascular growth and regression. At the heart of the tumour unfavourable environmental conditions prevail - hypoxia, acidity, lack of nutrients, failure of waste removal, and apoptosis rather than proliferation. Blood vessels and tumour cells are greatly decreased, but do not vanish, as tumour cells are shifting to anaerobic glycolysis, and blood vessels are turning into anti-apoptotic pathways - vascular survival ability (VSA). Thus, assessing vascular density (VD) by simply counting "hot spots" at the edge of a tumour, where conditions are most favourable, is futile; it may reflect tumour angiogenic activity (TAA), but is not representative of genuine tumour vasculature. By combining vessel counts at the invading tumour front with those of the inner tumour areas a complete picture of tumour VD can be achieved. The thus formed four patterns of vascularization, designated as "edvin" (edge vs inner tumour area), are: edvin 1: low TAA/low VSA; edvin 4: high TAA/high VSA; edvin 2: low TAA/high VSA; and edvin 3: high TAA/low VSA. It is expected that this scheme will prove useful in the field of chemoradiotherapy and anti-angiogenic treatment.
引用
收藏
页码:431 / 440
页数:10
相关论文
共 65 条
[1]  
Brekken RA, 1998, CANCER RES, V58, P1952
[2]   Lymphangiogenesis in malignant tumours: does it occur? [J].
Clarijs, R ;
Ruiter, DJ ;
de Waal, RMW .
JOURNAL OF PATHOLOGY, 2001, 193 (02) :143-146
[3]   TUMOR ANGIOGENESIS [J].
FOLKMAN, J .
ADVANCES IN CANCER RESEARCH, 1985, 43 :175-203
[4]  
FOX SB, 1993, CANCER RES, V53, P4161
[5]  
GAJA G, 1970, J NATL CANCER I, V44, P1269
[6]   CLINICAL IMPORTANCE OF THE DETERMINATION OF TUMOR ANGIOGENESIS IN BREAST-CARCINOMA - MUCH MORE THAN A NEW PROGNOSTIC TOOL [J].
GASPARINI, G ;
HARRIS, AL .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :765-782
[7]  
Geschwind JFH, 2002, CANCER RES, V62, P3909
[8]  
Giatromanolaki A, 1999, INT J CANCER, V80, P810, DOI 10.1002/(SICI)1097-0215(19990315)80:6<810::AID-IJC3>3.0.CO
[9]  
2-J
[10]  
Giatromanolaki A, 1999, CANCER-AM CANCER SOC, V86, P1421, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1421::AID-CNCR6>3.0.CO